LifeVantage Corporation (LFVN)
Nasdaq · Consumer Defensive · Packaged Foods
$6.03−0.66%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $75.9M
- P/E (trailing)
- 15.1
- Forward P/E
- 15.6
- Dividend yield
- 3.3%
- 52-week range
- $3.90 – $11.71
- 52-week change
- −34.38%
- EPS (trailing)
- $0.40
- Next earnings
- Nov 3, 2026
Fiscal year to Jun 2026
- Revenue
- $183M (−20.10%)
- Net income
- $5.1M
- Operating margin
- 3.3%
- Diluted EPS
- $0.40
- Free cash flow
- $6.7M
From the company’s annual report on SEC EDGAR.
About LifeVantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed…
Headquarters: Lehi, United States · 209 employees · lifevantage.com